Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the effect of FFR (Fractional flow reserve) guided Percutaneous Coronary Intervention in coronary tandem lesions.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seung-Jung Park
Collaborators
NCT05972070 · Myocardial Infarction, Percutaneous Transluminal Coronary Angioplasty, and more
NCT01186133 · Coronary Artery Disease, Percutaneous Transluminal Coronary Angioplasty
NCT02042300 · Percutaneous Transluminal Coronary Angioplasty, Coronary Artery Disease
NCT02939872 · Percutaneous Transluminal Coronary Angioplasty, Coronary Disease
NCT02831218 · Percutaneous Transluminal Coronary Angioplasty
Asan Medical Center
Seoul, Songpa-gu
Soon Chun Hyang University Hospital Bucheon
Bucheon-si
Gangwon National Univ. Hospital
Chuncheon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions